InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Curt Mikael von Euler-Chelpin. Director active across 1 company, notably XSpray Pharma AB (publ). Cumulatively, 1 filings have been logged. History available since 18 June 2026. The latest transaction was disclosed on 18 June 2026 (Purchase). Regulator: FIN-FSA. All data is accessible without signup.
1 of 1 declaration